Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)

9 Months Ended

Dec. 31, 2022

Changes in noncontrolling interests for the three and nine months ended December 31, 2022 were as follows:


(In millions)	Noncontrolling Interests
Balance, September 30, 2022	$	518
Net income attributable to noncontrolling interests	41

Payments to noncontrolling interests	(36)
Reclassification of recurring compensation to other accrued liabilities	(1)


Formation of an oncology research business	225
Derecognition of noncontrolling interests in McKesson Europe	(382)
Other	1
Balance, December 31, 2022	$	366


(In millions)	Noncontrolling Interests
Balance, March 31, 2022	$	480
Net income attributable to noncontrolling interests	123
Other comprehensive income	44
Payments to noncontrolling interests	(113)
Reclassification of recurring compensation to other accrued liabilities	(5)


Formation of an oncology research business	225
Derecognition of noncontrolling interests in McKesson Europe	(382)
Other	(6)
Balance, December 31, 2022	$	366

Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2021 were as follows:


(In millions)	Noncontrolling Interests
Balance, September 30, 2021	$	484
Net income attributable to noncontrolling interests	46
Other comprehensive loss	(2)
Payments to noncontrolling interests	(38)
Reclassification of recurring compensation to other accrued liabilities	(3)

Balance, December 31, 2021	$	487


(In millions)	Noncontrolling Interests		Redeemable Noncontrolling Interests
Balance, March 31, 2021	$	196	$	1,271
Net income attributable to noncontrolling interests	128		8
Other comprehensive income (loss)	(2)		3
Payments to noncontrolling interests	(117)		—
Reclassification of recurring compensation to other accrued liabilities	(5)		(8)
Exercises of Put Right	—		(983)
Reclassification of McKesson Europe redeemable noncontrolling interests	287		(287)
Other	—		(4)
Balance, December 31, 2021	$	487	$	—